Dianthus Therapeutics, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 |
|---|---|---|
| Operating Activities | ||
| Net Income | $-35.5M | $-9.4M |
| Depreciation & Amortization | $376.0K | $6.0K |
| Depreciation | — | — |
| Amortization | — | — |
| Stock-Based Compensation | $2.3M | $662.0K |
| Net Cash from Operating Activities | $-22.3M | $-6.5M |
| Investing Activities | ||
| Capital Expenditures | $2.2M | $139.0K |
| Business Acquisitions | — | — |
| Net Cash from Investing Activities | $-2.2M | $-139.0K |
| Financing Activities | ||
| Dividends Paid | — | — |
| Stock Repurchases | — | — |
| Net Cash from Financing Activities | $71.5M | $10.7M |
| Net Change in Cash | $47.0M | $4.0M |
| Free Cash Flow | $-24.5M | $-6.7M |